FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug
August 10, 2021 09:00 ET
|
Vitality Biopharma, Inc
CLEVELAND, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic...
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
June 15, 2021 08:19 ET
|
Biomerica, Inc.
IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 16% [1] (approximately 20 million patients)Broadens InFoods® global patent coverage with recently...
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Analysis
June 09, 2021 06:28 ET
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnosis (Laboratory Tests, Imaging...
Biomerica Reports Fiscal Year End May 31, 2020 Financial Results
September 01, 2020 08:19 ET
|
Biomerica, Inc.
Fiscal fourth quarter revenues increase 133.7% over the prior yearFiscal 2020 revenues increase 28.7% over fiscal 2019 New InFoods® patent granted for Singapore IRVINE, Calif., Sept. 01, 2020 ...
Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors
August 31, 2020 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced today the retirement of Janet Moore, the Company’s Chief Financial Officer. After many years of...
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial
June 29, 2020 21:39 ET
|
Biomerica, Inc.
InFoods® Diagnostic-Guided Therapy is designed to identify patient-specific foods that, when removed from the diet, may alleviate an individual's IBS symptoms Approximately 45 million Americans...
Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund
February 26, 2020 16:41 ET
|
Biomerica, Inc.
IRVINE, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) (the “Company” or “Biomerica”) announced today that the Company completed a private placement of $2 million of...
The asthma & allergy friendly® Certification Program Featured Its Certified Products to the Homebuilding Industry’s Leaders and Experts From Across the Globe at the 2020 NAHB International Builders Show and Kitchen & Bath Industry Show
January 28, 2020 12:00 ET
|
Allergy Standards Limited
WASHINGTON, Jan. 28, 2020 (GLOBE NEWSWIRE) -- The asthma & allergy friendly® Certification Program, which is jointly run by Allergy Standards Limited (ASL) and the Asthma and Allergy Foundation...
Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial
January 07, 2020 08:19 ET
|
Biomerica, Inc.
Texas Medical Center is the largest medical complex in the world with 10 million patient encounters per year and a 1,345-acre campus (50 million square feet of developed facilities)InFoods® Diagnostic...
LoRa Alliance® to Show How to Achieve Operational Excellence for Smart Buildings at Intelligent Building Systems (IBS) Paris 2019
September 23, 2019 05:00 ET
|
LoRa Alliance
PARIS, Sept. 23, 2019 (GLOBE NEWSWIRE) -- The LoRa Alliance®, the global association of companies backing the open LoRaWAN® standard for the Internet of Things (IoT) low-power wide-area networks...